Week 48 MDA Breakout Stocks - December 2021: Short-Term Picks To Give You An EdgeSeeking Alpha • 11/28/21
Vir Biotechnology: mAbs Gaining Traction After New South African Covid VariantSeeking Alpha • 11/28/21
CEO of Covid antibody maker Vir Biotech says their treatment 'stands up well' to all variantsCNBC • 11/17/21
US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1BBenzinga • 11/17/21
GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 TreatmentGlobeNewsWire • 11/17/21
The Wall Street Journal: U.S. government will buy more of GlaxoSmithKline and Vir's COVID antibody drugMarket Watch • 11/17/21
GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19Benzinga • 11/12/21
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection at AASLD The Liver Meeting®GlobeNewsWire • 11/12/21
Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19GlobeNewsWire • 11/12/21
Vir Biotechnology, Inc. (VIR) Beats Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/04/21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/04/21
Vir Biotechnology, Inc. (VIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 10/28/21
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2021 Financial Results on November 4, 2021GlobeNewsWire • 10/21/21
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at AASLD's The Liver Meeting® 2021GlobeNewsWire • 10/15/21
Vir Biotechnology to Participate in the H. C. Wainwright 2nd Annual Hepatitis B Virus (HBV) ConferenceGlobeNewsWire • 10/06/21